Prospects for nasal delivery of a pharmacologic agent for neuroprotective experimental therapy after prenatal hypoxia
И. Ф. Беленичев(Zaporizhzhia State Medical and Pharmaceutical University), Oleksandr Kamyshnyi(I.Horbachevsky Ternopil National Medical University), Dmytro Skoryna(Zaporizhzhia State Medical and Pharmaceutical University), Nina Bukhtiyarova(Zaporizhzhia State Medical and Pharmaceutical University), Pavlo Petakh(Kyiv School of Economics), E. Aliyeva(Zaporizhzhia State Medical and Pharmaceutical University), Kristina Burlaka(Zaporizhzhia State Medical and Pharmaceutical University), Victor Ryzhenko(Zaporizhzhia State Medical and Pharmaceutical University), Б. С. Бурлака(Zaporizhzhia State Medical and Pharmaceutical University)
Cited by 0
Related Papers
Effects of metformin on the gut microbiota: A systematic review
|Molecular Metabolism|2023|91
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
|Biomedicine & Pharmacotherapy|2023|70
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
|Antioxidants|2024|64
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions
|Biomedicines|2024|51
Current treatment options for leptospirosis: a mini-review
|Frontiers in Microbiology|2024|48